Gut Liver.
2022 Jul;16(4):501-502. 10.5009/gnl220186.
Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2531232
- DOI: http://doi.org/10.5009/gnl220186
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reactivation of Hepatitis B Virus in Patients with Rheumatologic Disease Treated with Biologic Disease Modifying Anti-rheumatic Drugs: Screening and Treatment
- Reactivation of Hepatitis B Virus Following Anti-Tumor Necrosis Factor-alpha Therapy
- Biological Therapy for Inflammatory Bowel Disease in Children
- Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
- Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
